STONY BROOK, N.Y.--(BUSINESS WIRE)--iCell Gene Therapeutics, a clinical stage biopharmaceutical company focused on immunotherapies for autoimmune disorders and cancer, today announced the publication ...
STONY BROOK, N.Y.--(BUSINESS WIRE)--iCell Gene Therapeutics, Inc., a clinical-stage biotechnology company focused on the research and development of proprietary CAR immunotherapies for patients with ...
MADISON, Wis., May 24, 2022 (GLOBE NEWSWIRE) -- FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem cell (iPSC) products, announced today ...
MADISON, Wis., Dec. 12, 2012 /PRNewswire/ -- Cellular Dynamics International (CDI), a leading commercial producer of human induced pluripotent stem cell (iPSC) lines and tissue cells, today announced ...
Cellular Dynamics International (CDI) has announced the publication of research demonstrating the use of human iPSC-derived iCell® Neurons to model Alzheimer’s disease (AD) and how they may be used in ...
Cellular Dynamics International (CDI) announced the commercial launch of human iCell® Neurons for use in neuroscience drug discovery, neurotoxicity screens, and other health research. This is the ...
BCMA-CD19 compound CAR (cCAR) therapy was safe and well tolerated and achieved proof of concept of complete humoral reset delivering long-term medication-free remission - iCell's BCMA-CD19 cCAR was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results